{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:36:22Z","timestamp":1790397382885,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004528","name":"Maastricht Universitair Medisch Centrum","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004528","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"Netherlands Organisation for Health Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008582","name":"McGill University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008582","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005326","name":"Yale University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001721","name":"Rijksuniversiteit Groningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005075","name":"Universitair Medisch Centrum Groningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005075","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008459","name":"Behavioural Science institute, Radboud University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008459","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007659","name":"Universiteit van Tilburg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.euroneuro.2026.112769","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T14:49:56Z","timestamp":1769093396000},"page":"112769","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Antipsychotic plasma concentration as predictor of movement disorders and cardiometabolic side-effects: A comparison with prescription dose"],"prefix":"10.1016","volume":"105","author":[{"given":"Yinzhao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris E","family":"Sommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Schoretsanitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Hamers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toon A W","family":"Scheurink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke J H","family":"Begemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiral S","family":"Gangadin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico J M","family":"van Beveren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Sommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieuwe","family":"de Haan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Veling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"van Os","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke","family":"Begemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanne","family":"Koops","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Machteld","family":"Marcelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn","family":"Kikkert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico","family":"van Beveren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nynke","family":"Boonstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bram-Sieben","family":"Rosema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.Roberto","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinan","family":"G\u00fcl\u00f6ks\u00fcz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joran","family":"Lokkerbol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Wijnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bodyl","family":"Brand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiral","family":"Gangadin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hag","family":"Erna van \u2019t","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla","family":"Oomen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alban","family":"Voppel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franciska","family":"de Beer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sterre","family":"Kamphuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Hamers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matej","family":"Djordjevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toon","family":"Scheurink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jort","family":"Noorman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese","family":"van Amelsvoort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Bak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Berendsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Truus","family":"van den Brink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Faber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Grootens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"de Jonge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henderikus","family":"Knegtering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Kurkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerdina Hendrika Maria","family":"Pijnenborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Staring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Veen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selene","family":"Veerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sybren","family":"Wiersma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Batalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Curfs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Jaap","family":"Hage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Graveland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joelle","family":"Hoornaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge","family":"Hobus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Huizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanne","family":"Koops","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P Roberto","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2026.112769_bib0001","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0257129","article-title":"Antipsychotic-induced extrapyramidal side effects: a systematic review and meta-analysis of observational studies","volume":"16","author":"Ali","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.euroneuro.2026.112769_bib0002","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00213-020-05715-5","article-title":"The usefulness of olanzapine plasma concentrations in monitoring treatment efficacy and metabolic disturbances in first-episode psychosis","volume":"238","author":"Arnaiz","year":"2021","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2026.112769_bib0003","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2165\/00023210-200418130-00004","article-title":"Impact of atypical antipsychotics on quality of life in patients with schizophrenia","volume":"18","author":"Awad","year":"2004","journal-title":"CNS Drugs"},{"key":"10.1016\/j.euroneuro.2026.112769_bib0004","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12991-021-00348-0","article-title":"Impact of adverse reactions to first-generation antipsychotics on treatment adherence in outpatients with schizophrenia: a cross-sectional study","volume":"20","author":"Bahta","year":"2021","journal-title":"Ann. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2026.112769_bib0005","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug-induced akathisia","volume":"154","author":"Barnes","year":"1989","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2026.112769_bib0006","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41431-023-01347-3","article-title":"Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics","volume":"32","author":"Beunk","year":"2024","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.euroneuro.2026.112769_bib0007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003821","article-title":"Drug-induced orthostatic hypotension: a systematic review and meta-analysis of randomised controlled trials","volume":"18","author":"Bhanu","year":"2021","journal-title":"PLoS Med."},{"key":"10.1016\/j.euroneuro.2026.112769_bib0008","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1017\/S0033291721004591","article-title":"Antipsychotic medication for women with schizophrenia spectrum disorders","volume":"52","author":"Brand","year":"2022","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2026.112769_bib0009","first-page":"14","article-title":"Atypical antipsychotics and metabolic syndrome: from molecular mechanisms to clinical differences","author":"Carli","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.euroneuro.2026.112769_bib0010","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/acps.12794","article-title":"Effects of age and gender on the serum levels of clozapine, olanzapine, risperidone, and quetiapine","volume":"136","author":"Castberg","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2026.112769_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105454","article-title":"An umbrella review of adverse effects associated with antipsychotic medications: the need for complementary study designs","volume":"155","author":"Chow","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.euroneuro.2026.112769_bib0012","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/JCP.0b013e3181a289cb","article-title":"Olanzapine plasma concentrations after treatment with 10, 20, and 40 mg\/d in patients with schizophrenia: an analysis of correlations with efficacy, weight gain, and prolactin concentration","volume":"29","author":"Citrome","year":"2009","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2026.112769_bib0013","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1208\/s12248-010-9247-4","article-title":"Dopamine D2 occupancy as a biomarker for antipsychotics: quantifying the relationship with efficacy and extrapyramidal symptoms","volume":"13","author":"de Greef","year":"2011","journal-title":"AAPS J."},{"key":"10.1016\/j.euroneuro.2026.112769_bib0014","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nrendo.2011.156","article-title":"Metabolic and cardiovascular adverse effects associated with antipsychotic drugs","volume":"8","author":"De Hert","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.euroneuro.2026.112769_bib0015","article-title":"The impact of weight gain on antipsychotic nonadherence or discontinuation: a systematic review and meta-analysis","author":"De","year":"2024","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2026.112769_bib0016","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.121.010573","article-title":"Orthostatic hypotension: management of a complex, but common, medical problem","volume":"15","author":"Fedorowski","year":"2022","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"10.1016\/j.euroneuro.2026.112769_bib0017","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/00007691-200312000-00006","article-title":"Investigation of target plasma concentration-effect relationships for olanzapine in schizophrenia","volume":"25","author":"Fellows","year":"2003","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.euroneuro.2026.112769_bib0018","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/wps.21315","article-title":"Risk of relapse during tapering of antipsychotic medication after a first psychotic episode: association with D2 receptor affinity but not with tapering speed","volume":"24","author":"Gangadin","year":"2025","journal-title":"World Psychiatry"},{"key":"10.1016\/j.euroneuro.2026.112769_bib0019","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1600-0447.1993.tb03366.x","article-title":"The St. Hans Rating Scale for extrapyramidal syndromes: reliability and validity","volume":"87","author":"Gerlach","year":"1993","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2026.112769_bib0020","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2165\/11591710-000000000-00000","article-title":"Antipsychotic pharmacotherapy and orthostatic hypotension: identification and management","volume":"25","author":"Gugger","year":"2011","journal-title":"CNS Drugs"},{"key":"10.1016\/j.euroneuro.2026.112769_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.832209","article-title":"Molecular imaging of dopamine partial agonists in humans: implications for clinical practice","volume":"13","author":"Hart","year":"2022","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.euroneuro.2026.112769_bib0022","doi-asserted-by":"crossref","unstructured":"Hedeker, D., Gibbons, R.D., 1997. Application of random-effects pattern-mixture models for missing data in longitudinal studies. 2, 64\u201378.","DOI":"10.1037\/\/1082-989X.2.1.64"},{"key":"10.1016\/j.euroneuro.2026.112769_bib0023","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1055\/s-0043-116492","article-title":"Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017","volume":"51","author":"Hiemke","year":"2018","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.euroneuro.2026.112769_bib0024","doi-asserted-by":"crossref","first-page":"e245","DOI":"10.1038\/emm.2016.81","article-title":"Regulation and function of AMPK in physiology and diseases","volume":"48","author":"Jeon","year":"2016","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.euroneuro.2026.112769_bib0025","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s002280050163","article-title":"Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine","volume":"51","author":"Jeppesen","year":"1996","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.euroneuro.2026.112769_bib0026","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00228-010-0850-1","article-title":"The role of CYP2D6 and ABCB1 pharmacogenetics in drug-naive patients with first-episode schizophrenia treated with risperidone","volume":"66","author":"Jovanovic","year":"2010","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.euroneuro.2026.112769_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107704","article-title":"Antipsychotics: mechanisms underlying clinical response and side-effects and novel treatment approaches based on pathophysiology","volume":"172","author":"Kaar","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2026.112769_bib0028","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41537-022-00211-5","article-title":"Association between olanzapine concentration and metabolic dysfunction in drug-naive and chronic patients: similarities and differences","volume":"8","author":"Kang","year":"2022","journal-title":"Schizophrenia (Heidelb)"},{"key":"10.1016\/j.euroneuro.2026.112769_bib0029","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/JCP.0b013e3182983ffa","article-title":"Estimating dopamine D(2) receptor occupancy for doses of 8 antipsychotics: a meta-analysis","volume":"33","author":"Lako","year":"2013","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2026.112769_bib0030","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4093\/dmj.2022.0431","article-title":"Psychotic disorders and the risk of type 2 diabetes mellitus, atherosclerotic cardiovascular diseases, and all-cause mortality: a population-based matched cohort study","volume":"48","author":"Lee","year":"2024","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.euroneuro.2026.112769_bib0031","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1176\/appi.ajp.2019.19010034","article-title":"Dose-response meta-analysis of antipsychotic drugs for acute schizophrenia","volume":"177","author":"Leucht","year":"2020","journal-title":"Am. J. Psychiatry"},{"issue":"Suppl 1","key":"10.1016\/j.euroneuro.2026.112769_bib0032","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1093\/schbul\/sbv167","article-title":"Dose equivalents for antipsychotic drugs: the DDD method","volume":"42","author":"Leucht","year":"2016","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2026.112769_bib0033","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/schbul\/sbu001","article-title":"Dose equivalents for second-generation antipsychotics: the minimum effective dose method","volume":"40","author":"Leucht","year":"2014","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2026.112769_bib0034","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.jesp.2013.03.013","article-title":"Detecting outliers: do not use standard deviation around the mean, use absolute deviation around the median","volume":"49","author":"Leys","year":"2013","journal-title":"J. Exp. Soc. Psychol."},{"key":"10.1016\/j.euroneuro.2026.112769_bib0035","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41537-022-00270-8","article-title":"Extrapyramidal symptoms predict cognitive performance after first-episode psychosis","volume":"8","author":"Lindgren","year":"2022","journal-title":"Schizophrenia (Heidelb)"},{"key":"10.1016\/j.euroneuro.2026.112769_bib0036","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1214\/18-STS681","article-title":"Statistical analysis of zero-inflated nonnegative continuous data a review","volume":"34","author":"Liu","year":"2019","journal-title":"Stat. Sci."},{"key":"10.1016\/j.euroneuro.2026.112769_bib0037","article-title":"The effects of antipsychotic dose reduction on movement disorders and cardiometabolic indices in patients remitted from a first episode of psychosis","author":"Liu","year":"2025","journal-title":"Schizophr. Bull."},{"issue":"Suppl 1","key":"10.1016\/j.euroneuro.2026.112769_bib0038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1092852915000838","article-title":"The clinical challenges of akathisia","volume":"20","author":"Lohr","year":"2015","journal-title":"CNS Spectr."},{"key":"10.1016\/j.euroneuro.2026.112769_bib0039","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3389\/fpsyt.2018.00622","article-title":"Antipsychotics, metabolic adverse effects, and cognitive function in schizophrenia","volume":"9","author":"MacKenzie","year":"2018","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.euroneuro.2026.112769_bib0040","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s40262-018-0664-3","article-title":"Clinical pharmacokinetics of Atypical antipsychotics: an update","volume":"57","author":"Mauri","year":"2018","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.euroneuro.2026.112769_bib0041","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/schbul\/sbr148","article-title":"Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders\u2013a systematic review and meta-analysis","volume":"39","author":"Mitchell","year":"2013","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2026.112769_bib0042","doi-asserted-by":"crossref","first-page":"E624","DOI":"10.1152\/ajpendo.00502.2010","article-title":"Atypical antipsychotic drugs perturb AMPK-dependent regulation of hepatic lipid metabolism","volume":"300","author":"Oh","year":"2011","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.euroneuro.2026.112769_bib0043","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S2215-0366(16)30262-0","article-title":"The association between first-episode psychosis and abnormal glycaemic control: systematic review and meta-analysis","volume":"3","author":"Perry","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.euroneuro.2026.112769_bib0044","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S2215-0366(21)00114-0","article-title":"Development and external validation of the psychosis metabolic risk calculator (PsyMetRiC): a cardiometabolic risk prediction algorithm for young people with psychosis","volume":"8","author":"Perry","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.euroneuro.2026.112769_bib0045","doi-asserted-by":"crossref","DOI":"10.1097\/01.jcp.0000162800.64378.82","article-title":"The association of weight gain and olanzapine plasma concentrations","volume":"25","author":"Perry","year":"2005","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2026.112769_bib66","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2307\/271063","article-title":"Bayesian model selection in social research","volume":"25","author":"Raftery","year":"1995","journal-title":"Sociol. Methodol."},{"key":"10.1016\/j.euroneuro.2026.112769_bib0046","doi-asserted-by":"crossref","first-page":"6E","DOI":"10.1016\/0002-9149(86)90716-2","article-title":"Alpha-adrenergic receptors and blood pressure control","volume":"57","author":"Reid","year":"1986","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.euroneuro.2026.112769_bib0047","doi-asserted-by":"crossref","unstructured":"Roth, B.L., Lopez, E., Patel, S., Kroeze, W.K., 2000. The multiplicity of serotonin receptors: uselessly diverse molecules or an embarrassment of riches? 6, 252\u2013262.","DOI":"10.1177\/107385840000600408"},{"key":"10.1016\/j.euroneuro.2026.112769_bib0048","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00001648-199001000-00010","article-title":"No adjustments are needed for multiple comparisons","volume":"1","author":"Rothman","year":"1990","journal-title":"Epidemiology"},{"key":"10.1016\/j.euroneuro.2026.112769_bib0049","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.22r14490","article-title":"Comparative effects of 11 antipsychotics on weight gain and metabolic function in patients with acute schizophrenia: a dose-response meta-analysis","volume":"84","author":"Sabe","year":"2023","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2026.112769_bib0050","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0140-6736(21)01997-8","article-title":"Comparative efficacy and tolerability of 32 oral and long-acting injectable antipsychotics for the maintenance treatment of adults with schizophrenia: a systematic review and network meta-analysis","volume":"399","author":"Schneider-Thoma","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.euroneuro.2026.112769_bib0051","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/bcpt.13715","article-title":"Olanzapine-associated dose-dependent alterations for weight and metabolic parameters in a prospective cohort","volume":"130","author":"Schoretsanitis","year":"2022","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.euroneuro.2026.112769_bib0052","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/YIC.0000000000000131","article-title":"Risperidone-induced extrapyramidal side effects: is the need for anticholinergics the consequence of high plasma concentrations?","volume":"31","author":"Schoretsanitis","year":"2016","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2026.112769_bib0053","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19cs13169","volume":"81","author":"Schoretsanitis","year":"2020","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2026.112769_bib0054","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1038\/s41380-023-02203-y","article-title":"Antipsychotic dose, dopamine D2 receptor occupancy and extrapyramidal side-effects: a systematic review and dose-response meta-analysis","volume":"28","author":"Siafis","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2026.112769_bib0055","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1124\/dmd.30.8.861","article-title":"Pharmacokinetic-pharmacodynamic analysis of the glucose-lowering effect of metformin in diabetic rats reveals first-pass pharmacodynamic effect","volume":"30","author":"Stepensky","year":"2002","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.euroneuro.2026.112769_bib0056","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0033291724002873","article-title":"Suicidality and use of psychotropic medications in patients with schizophrenia: a prospective cohort study","volume":"54","author":"Stromme","year":"2024","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2026.112769_bib0057","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00702-022-02485-6","article-title":"Therapeutic drug monitoring in children and adolescents with schizophrenia and other psychotic disorders using risperidone","volume":"129","author":"Taurines","year":"2022","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.euroneuro.2026.112769_bib0058","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/JCP.0b013e318218d339","article-title":"Predicting dopamine D(2) receptor occupancy from plasma levels of antipsychotic drugs: a systematic review and pooled analysis","volume":"31","author":"Uchida","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2026.112769_bib0059","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10082010","article-title":"Pathophysiological mechanisms of antipsychotic-induced parkinsonism","volume":"10","author":"Vaiman","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.euroneuro.2026.112769_bib0060","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1161\/STROKEAHA.123.040499","article-title":"Cognitive impairment in patients with cardiac disease: implications for clinical practice","volume":"54","author":"van Nieuwkerk","year":"2023","journal-title":"Stroke"},{"key":"10.1016\/j.euroneuro.2026.112769_bib0061","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00031305.2019.1583913","article-title":"Moving to a world beyond \u201cp\u2009<\u20090.05\u201d","volume":"73","author":"Wasserstein","year":"2019","journal-title":"Am. Stat."},{"key":"10.1016\/j.euroneuro.2026.112769_bib0062","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.22r14626","article-title":"Therapeutic reference range for olanzapine in schizophrenia: systematic review on blood concentrations, clinical effects, and dopamine receptor occupancy","volume":"84","author":"Wesner","year":"2023","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2026.112769_bib0063","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/schbul\/sbac001","article-title":"Antipsychotic-induced weight gain: dose-response meta-analysis of randomized controlled trials","volume":"48","author":"Wu","year":"2022","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2026.112769_bib0064","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.euroneuro.2023.03.015","article-title":"Antipsychotic-induced akathisia in adults with acute schizophrenia: a systematic review and dose-response meta-analysis","volume":"72","author":"Wu","year":"2023","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2026.112769_bib0065","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1124\/dmd.119.086744","article-title":"Drug concentration asymmetry in tissues and plasma for small molecule-related therapeutic modalities","volume":"47","author":"Zhang","year":"2019","journal-title":"Drug Metab. Dispos."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X26000106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X26000106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T12:32:48Z","timestamp":1771245168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X26000106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":66,"alternative-id":["S0924977X26000106"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2026.112769","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antipsychotic plasma concentration as predictor of movement disorders and cardiometabolic side-effects: A comparison with prescription dose","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2026.112769","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"112769"}}